Med-Chemist : "Quintessential Medicinal Chemistry"
Wednesday, December 15, 2021
FDA Approves Livtencity (maribavir) for Post-Transplant Cytomegalovirus (CMV) Infection/Disease
›
Takeda Pharmaceutical Company Limited (“Takeda”) announced the U.S. Food and Drug Administration (FDA) approval of Livtencity ™ (...
Tuesday, December 14, 2021
FDA Approves Eprontia (topiramate) Oral Solution for Epilepsy and Preventive Treatment of Migraine
›
In continuation of my update on topiramate... Azurity Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval...
Monday, December 13, 2021
FDA Approves Scemblix (asciminib) for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML)
›
Novartis announced the US Food and Drug Administration (FDA) approval of Scemblix ® (asciminib) for the treatment of chronic myeloid le...
Friday, December 10, 2021
FDA Approves Tyrvaya (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease...
›
Oyster Point Pharma, Inc. (Nasdaq: OYST), announced the U.S. Food and Drug Administration (FDA) approval of Tyrvaya (varenicline so...
Thursday, December 9, 2021
FDA Approves Xipere (triamcinolone acetonide injectable suspension) for the Treatment of Macular Edema Associated with Uveitis
›
In continuation of my update on triamcinolone ....... Biomedical, Inc., a biopharmaceutical company announced the U.S. Food and Drug A...
Wednesday, December 8, 2021
FDA Approves Tavneos (avacopan) for the Adjunctive Treatment of ANCA-Associated Vasculitis
›
ChemoCentryx, Inc., (Nasdaq: CCXI), announced the U.S. Food and Drug Administration (FDA) approval of Tavneos (avacopan), an orally a...
Tuesday, December 7, 2021
FDA Approves Livmarli (maralixibat) for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
›
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), announced the U.S. Food and Drug Administration (FDA) approval of Livmarli (maralixibat) o...
Monday, December 6, 2021
FDA Approves Qulipta (atogepant) Oral CGRP Receptor Antagonist for the Preventive Treatment of Migraine
›
In continuation of my update on Qulipta (atogepant), AbbVie (NYSE: ABBV) announced the U.S. Food and Drug Administration (FDA) appro...
Saturday, December 4, 2021
FDA Approves Opzelura (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD)
›
In continuation of my update on Opzelura (ruxolitinib) , Incyte (Nasdaq:INCY) announced the U.S. Food and Drug Administration (FDA) ap...
Thursday, December 2, 2021
FDA Approves Exkivity (mobocertinib) for EGFR Exon20 Insertion+ Non-Small Cell Lung Cancer (NSCLC)
›
Takeda Pharmaceutical Company Limited announced the U.S. Food and Drug Administration (FDA) approval of Exkivity (mobocertinib) for...
Wednesday, December 1, 2021
FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine
›
Impel NeuroPharma, Inc. (NASDAQ: IMPL), announced the U.S. Food and Drug Administration (FDA) approval of Trudhesa ™ (dihydroergotamine...
‹
›
Home
View web version